Aralez Bio
Berkeley, United States · $12.0M raised
- Headquarters
- Berkeley, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- aralezbio.com
- Total Funding
- $12.0M
- Last Round
- $12.0M Series AOct 2024
- Rounds
- 2
About
Aralez Bio is a Berkeley, California-based biotechnology platform company that harnesses engineered enzymes and directed evolution to manufacture noncanonical amino acids (ncAAs) for use in peptide therapeutics and sustainable chemical production. The company’s proprietary enzymatic approach enables high-purity, cost-effective, and scalable synthesis of specialty amino acids that were previously difficult or expensive to produce, replacing traditional multi-step chemical synthesis with greener biocatalytic processes. Aralez Bio operates a manufacturing plant in Berkeley and serves pharmaceutical and biotech customers seeking faster, more sustainable raw material supply chains.
Summary
Aralez Bio is a Biotech company based in Berkeley, United States. It has raised $12.0M in total across 2 rounds, most recently a $12.0M Series A round in Oct 2024. Investors include Paladin Capital Group, Fifty Years and Good Growth Capital.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
